Citation Tools
PDFImmunotherapy biomarkers
Original research
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival